Spyre Therapeutics Inc Sustainability Reports
Spyre Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing next-generation therapeutics for inflammatory bowel disease and other immune-mediated diseases. The company leverages advanced antibody engineering and combination therapies to improve patient treatments.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 52990017AIJPRH3HQH40
FIGI: BBG0067L94C1
2 reports from 2023 to 2024